Purification of Double‐Stranded RNA Impurities From In Vitro‐Transcribed mRNA Using Size‐Exclusion Chromatography

dsRNA is a highly immunogenic byproduct generated during in vitro transcription of mRNA, leading to unwanted immunostimulatory responses and reduced vaccine efficacy. Removal of dsRNA impurities from mRNA is challenging, as they share similar physicochemical properties. Here, we present a lab-scale size-exclusion chromatography method that effectively separates dsRNA impurities from mRNA. This method achieves baseline resolution between dsRNA impurities and mRNA (resolution factor of 1.6) while maintaining high recovery of the target mRNA (81.8%). This work introduces a novel chromatographic strategy for the removal of dsRNA from mRNA therapeutics.

Authors

Institutions

Publication Details

Journal
Biomedical Chromatography
Published
2026-06-17
DOI
https://doi.org/10.1002/bmc.70528
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Purification of Double‐Stranded RNA Impurities From In Vitro‐Transcribed mRNA Using Size‐Exclusion Chromatography

Karen W. Phinney, Mark S. Lowenthal, Kyle J. Tynan, Trina Mouchahoir
Biomedical Chromatography
RNA Interference and Gene Delivery
article

Purification of Double‐Stranded RNA Impurities From In Vitro‐Transcribed mRNA Using Size‐Exclusion Chromatography

Karen W. Phinney, Mark S. Lowenthal, Kyle J. Tynan, Trina Mouchahoir
article en

Abstract

dsRNA is a highly immunogenic byproduct generated during in vitro transcription of mRNA, leading to unwanted immunostimulatory responses and reduced vaccine efficacy. Removal of dsRNA impurities from mRNA is challenging, as they share similar physicochemical properties. Here, we present a lab-scale size-exclusion chromatography method that effectively separates dsRNA impurities from mRNA. This method achieves baseline resolution between dsRNA impurities and mRNA (resolution factor of 1.6) while maintaining high recovery of the target mRNA (81.8%). This work introduces a novel chromatographic strategy for the removal of dsRNA from mRNA therapeutics.

Biomedical ChromatographyVol. 40(7)
National Institute of Standards and Technology (US), Research Institute for Bioscience and Biotechnology (NP), Advanced Bioscience Laboratories (United States) (US)
Reduced inequalities
Openalex Percentile: Top 12%
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.